2025-03-11 23:57:46
Latest Post
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Hexaware Inaugurates Global Business Headquarters in Jersey City
HCLTech among Ethisphere's 2025 World's Most Ethical Companies®
Ind-Swift Laboratories Ltd receives 'Best Employer Brand - Punjab 2025' by World HRD Congress
Stock Report
Torrent Pharmaceuticals Ltd reports Rs. 312 crores consolidated profit in Q2 FY23
Posted On : 2022-10-23 21:33:23( TIMEZONE : IST )
Torrent Pharmaceuticals Limited has reported Consolidated financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 2307 crores during the period ended September 30, 2022 as compared to Rs. 2377 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 312 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 354 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 9.22 for the period ended September 30, 2022 as compared to Rs. 10.45 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 2307 crs | ₹2377 crs |  -2.94% |
| Net Profit | ₹312 crs | ₹354 crs | -11.86% |
| EPS | ₹9.22 | ₹10.45 | -11.77% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 2307 crores during the period ended September 30, 2022 as compared to Rs.2188 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.312 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.316 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.9.22 for the period ended September 30, 2022 as compared to Rs.9.32 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 2307 crs | ₹2188 crs |  5.44% |
| Net Profit | ₹312 crs | ₹316 crs | -1.27% |
| EPS | ₹9.22 | ₹9.32 | -1.07% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.4684 crores during the 6 Months period ended September 30, 2022 as compared to Rs.4362 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.666 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.646 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.19.67 for the 6 Months period ended September 30, 2022 as compared to Rs.19.08 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹4684 crs | ₹4362 crs | 7.38% |
| Net Profit | ₹666 crs | ₹646 crs | 3.10% |
| EPS | ₹19.67 | ₹19.08 | 3.09% |
Shares of Torrent Pharmaceuticals Limited was last trading in BSE at Rs. 1593.70 as compared to the previous close of Rs. 1577.85. The total number of shares traded during the day was 4096 in over 808 trades.
The stock hit an intraday high of Rs. 1606.85 and intraday low of 1560.20. The net turnover during the day was Rs. 6517468.00.
